{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:01:50Z","timestamp":1792616510256,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03886-1","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T18:32:37Z","timestamp":1763404357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Real-world comparison of doxorubicin\u2013ifosfamide versus gemcitabine\u2013docetaxel regimens in metastatic uterine leiomyosarcoma: a multicenter retrospective study"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8804-7636","authenticated-orcid":false,"given":"Salih","family":"Tunbekici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1478-9383","authenticated-orcid":false,"given":"Gokhan","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8857-2983","authenticated-orcid":false,"given":"Haydar Cagatay","family":"Yuksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9782-6807","authenticated-orcid":false,"given":"Caner","family":"Acar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2744-6331","authenticated-orcid":false,"given":"Imge","family":"Ak\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8091-8760","authenticated-orcid":false,"given":"Hasan","family":"Aslanhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7192-6770","authenticated-orcid":false,"given":"Mert","family":"Isc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5665-911X","authenticated-orcid":false,"given":"Ceren","family":"Kabaoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6747-8264","authenticated-orcid":false,"given":"Hamit","family":"Bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2538-8569","authenticated-orcid":false,"given":"Abdullah","family":"Sakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2444-6587","authenticated-orcid":false,"given":"Alper","family":"Coskun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4841-7994","authenticated-orcid":false,"given":"Mustafa","family":"Seyyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7730-6946","authenticated-orcid":false,"given":"Mehmet S\u0131dd\u0131k","family":"Dilek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3090-8696","authenticated-orcid":false,"given":"Mahmut","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4696-1723","authenticated-orcid":false,"given":"Ali","family":"Solmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9110-4280","authenticated-orcid":false,"given":"Teyfik","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1132-2825","authenticated-orcid":false,"given":"Evrican","family":"Zin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3445-7001","authenticated-orcid":false,"given":"Aytac","family":"Terzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1650-154X","authenticated-orcid":false,"given":"Fatih","family":"Kus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9797-8037","authenticated-orcid":false,"given":"Ilg\u0131n Koc","family":"Kus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0598-389X","authenticated-orcid":false,"given":"Zafer","family":"Ar\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9753-8517","authenticated-orcid":false,"given":"Ali","family":"Aytac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5257-563X","authenticated-orcid":false,"given":"\u00d6zge","family":"Demirk\u0131ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4380-9419","authenticated-orcid":false,"given":"Bilgin","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7870-8741","authenticated-orcid":false,"given":"Havva","family":"Yesil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1053-0668","authenticated-orcid":false,"given":"Sedat","family":"Biter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8696-0525","authenticated-orcid":false,"given":"Tolga","family":"Koseci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8713-7613","authenticated-orcid":false,"given":"Ertugrul","family":"Bayram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8625-0761","authenticated-orcid":false,"given":"Ahmet","family":"Unsal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6432-5432","authenticated-orcid":false,"given":"Ahmet","family":"Ozveren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0499-8918","authenticated-orcid":false,"given":"Alper","family":"Sev\u0131nc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6376-8399","authenticated-orcid":false,"given":"Duygu","family":"Ozask\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3291-8134","authenticated-orcid":false,"given":"Meltem","family":"Baykara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6654-3815","authenticated-orcid":false,"given":"Ahmet","family":"Unlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9762-9857","authenticated-orcid":false,"given":"Ar\u0131f","family":"Kus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7310-9328","authenticated-orcid":false,"given":"Cengiz","family":"Karacin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3337-2188","authenticated-orcid":false,"given":"Merih","family":"Yalc\u0131ner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0698-777X","authenticated-orcid":false,"given":"Galip Can","family":"Uyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3835-2741","authenticated-orcid":false,"given":"Osman","family":"Sutcuoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1680-0391","authenticated-orcid":false,"given":"Esmanur","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2749-9414","authenticated-orcid":false,"given":"Teoman","family":"Sakalar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1976-3951","authenticated-orcid":false,"given":"Elif","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1549-7326","authenticated-orcid":false,"given":"Gamze","family":"Emin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6067-5646","authenticated-orcid":false,"given":"Atilla","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9140-1453","authenticated-orcid":false,"given":"Ceren","family":"Mordag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6325-6175","authenticated-orcid":false,"given":"Irem","family":"ugurlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0333-7405","authenticated-orcid":false,"given":"Ilhan","family":"Hac\u0131bekiroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3943-7871","authenticated-orcid":false,"given":"Ibrahim","family":"Tunbekici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1392-6753","authenticated-orcid":false,"given":"P\u0131nar","family":"Gursoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0062-6105","authenticated-orcid":false,"given":"Ulus Ali","family":"Sanli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6180-713X","authenticated-orcid":false,"given":"Erdem","family":"Goker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"issue":"1","key":"3886_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"3886_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020294","volume":"6","author":"F Ducimeti\u00e8re","year":"2011","unstructured":"Ducimeti\u00e8re F, Lurkin A, Ranch\u00e8re-Vince D, Decouvelaere AV, P\u00e9oc\u2019h M, Istier L, et al. Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing. PLoS ONE. 2011;6(8):e20294. https:\/\/doi.org\/10.1371\/journal.pone.0020294.","journal-title":"PLoS ONE"},{"issue":"1","key":"3886_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/PAP.0000000000000284","volume":"28","author":"JH Choi","year":"2021","unstructured":"Choi JH, Ro JY. The 2020 WHO classification of tumors of soft tissue: selected changes and new entities. Adv Anat Pathol. 2021;28(1):44\u201358. https:\/\/doi.org\/10.1097\/PAP.0000000000000284.","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"3886_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s11864-021-00928-y","volume":"23","author":"B Kasper","year":"2022","unstructured":"Kasper B, D\u2019Ambrosio L, Davis EJ, Ingham M, Broto JM, Trent JC, et al. What clinical trials are needed for treatment of leiomyosarcoma? Curr Treat Options Oncol. 2022;23(3):439\u201349. https:\/\/doi.org\/10.1007\/s11864-021-00928-y.","journal-title":"Curr Treat Options Oncol"},{"issue":"3","key":"3886_CR5","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.ygyno.2018.09.010","volume":"151","author":"ME Roberts","year":"2018","unstructured":"Roberts ME, Aynardi JT, Chu CS. Uterine leiomyosarcoma: a review of the literature and update on management options. Gynecol Oncol. 2018;151(3):562\u201372. https:\/\/doi.org\/10.1016\/j.ygyno.2018.09.010.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"3886_CR6","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/clinpract11040103","volume":"11","author":"S Kostov","year":"2021","unstructured":"Kostov S, Kornovski Y, Ivanova V, Dzhenkov D, Metodiev D, Watrowski R, et al. New aspects of sarcomas of uterine corpus-a brief narrative review. Clin Pract. 2021;11(4):878\u2013900. https:\/\/doi.org\/10.3390\/clinpract11040103.","journal-title":"Clin Pract"},{"issue":"1","key":"3886_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ygyno.2017.02.012","volume":"145","author":"BL Seagle","year":"2017","unstructured":"Seagle BL, Sobecki-Rausch J, Strohl AE, Shilpi A, Grace A, Shahabi S. Prognosis and treatment of uterine leiomyosarcoma: a National Cancer Database study. Gynecol Oncol. 2017;145(1):61\u201370. https:\/\/doi.org\/10.1016\/j.ygyno.2017.02.012.","journal-title":"Gynecol Oncol"},{"issue":"4 Suppl","key":"3886_CR8","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1002\/cncr.2820710440","volume":"71","author":"FJ Major","year":"1993","unstructured":"Major FJ, Blessing JA, Silverberg SG, Morrow CP, Creasman WT, Currie JL, et al. Prognostic factors in early-stage uterine sarcoma. A gynecologic oncology group study. Cancer. 1993;71(4 Suppl):1702\u20139. https:\/\/doi.org\/10.1002\/cncr.2820710440.","journal-title":"Cancer"},{"issue":"1","key":"3886_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/PGP.0000000000000284","volume":"36","author":"C Bartosch","year":"2017","unstructured":"Bartosch C, Afonso M, Pires-Lu\u00eds AS, Galaghar A, Guimar\u00e3es M, Antunes L, et al. Distant metastases in uterine leiomyosarcomas: the wide variety of body sites and time intervals to metastatic relapse. Int J Gynecol Pathol. 2017;36(1):31\u201341. https:\/\/doi.org\/10.1097\/PGP.0000000000000284.","journal-title":"Int J Gynecol Pathol"},{"issue":"7","key":"3886_CR10","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s11864-024-01214-3","volume":"25","author":"D Lewis","year":"2024","unstructured":"Lewis D, Liang A, Mason T, Ferriss JS. Current treatment options: uterine sarcoma. Curr Treat Options Oncol. 2024;25(7):829\u201353. https:\/\/doi.org\/10.1007\/s11864-024-01214-3.","journal-title":"Curr Treat Options Oncol"},{"issue":"9","key":"3886_CR11","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1056\/NEJMoa2403394","volume":"391","author":"P Pautier","year":"2024","unstructured":"Pautier P, Italiano A, Piperno-Neumann S, Chevreau C, Penel N, Firmin N, et al. Doxorubicin-trabectedin with trabectedin maintenance in leiomyosarcoma. N Engl J Med. 2024;391(9):789\u201399. https:\/\/doi.org\/10.1056\/NEJMoa2403394.","journal-title":"N Engl J Med"},{"issue":"12","key":"3886_CR12","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1200\/JCO.2002.11.050","volume":"20","author":"ML Hensley","year":"2002","unstructured":"Hensley ML, Maki R, Venkatraman E, Geller G, Lovegren M, Aghajanian C, et al. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol. 2002;20(12):2824\u201331. https:\/\/doi.org\/10.1200\/JCO.2002.11.050.","journal-title":"J Clin Oncol"},{"issue":"3","key":"3886_CR13","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ygyno.2008.02.024","volume":"109","author":"ML Hensley","year":"2008","unstructured":"Hensley ML, Blessing JA, Degeest K, Abulafia O, Rose PG, Homesley HD. Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study. Gynecol Oncol. 2008;109(3):323\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2008.02.024.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"3886_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ygyno.2008.03.010","volume":"109","author":"ML Hensley","year":"2008","unstructured":"Hensley ML, Blessing JA, Mannel R, Rose PG. Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial. Gynecol Oncol. 2008;109(3):329\u201334. https:\/\/doi.org\/10.1016\/j.ygyno.2008.03.010.","journal-title":"Gynecol Oncol"},{"issue":"9","key":"3886_CR15","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1634\/theoncologist.2011-0467","volume":"17","author":"P Pautier","year":"2012","unstructured":"Pautier P, Floquet A, Penel N, Piperno-Neumann S, Isambert N, Rey A, et al. Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study). Oncologist. 2012;17(9):1213\u201320. https:\/\/doi.org\/10.1634\/theoncologist.2011-0467.","journal-title":"Oncologist"},{"key":"3886_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13569-015-0029-8","volume":"5","author":"B Seddon","year":"2015","unstructured":"Seddon B, Scurr M, Jones RL, Wood Z, Propert-Lewis C, Fisher C, et al. A phase II trial to assess the activity of gemcitabine and docetaxel as first line chemotherapy treatment in patients with unresectable leiomyosarcoma. Clin Sarcoma Res. 2015;5:13. https:\/\/doi.org\/10.1186\/s13569-015-0029-8.","journal-title":"Clin Sarcoma Res"},{"issue":"9","key":"3886_CR17","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1200\/JCO.2004.08.043","volume":"22","author":"KM Leu","year":"2004","unstructured":"Leu KM, Ostruszka LJ, Shewach D, Zalupski M, Sondak V, Biermann JS, et al. Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma. J Clin Oncol. 2004;22(9):1706\u201312. https:\/\/doi.org\/10.1200\/JCO.2004.08.043.","journal-title":"J Clin Oncol"},{"issue":"3","key":"3886_CR18","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/ijc.21867","volume":"1","author":"JO Bay","year":"2006","unstructured":"Bay JO, Ray-Coquard I, Fayette J, Leyvraz S, Cherix S, Piperno-Neumann S, et al. Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis. Int J Cancer. 2006;1(3):706\u201311. https:\/\/doi.org\/10.1002\/ijc.21867.","journal-title":"Int J Cancer"},{"issue":"19","key":"3886_CR19","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1200\/JCO.2006.10.4117","volume":"25","author":"RG Maki","year":"2007","unstructured":"Maki RG, Wathen JK, Patel SR, Priebat DA, Okuno SH, Samuels B, et al. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]. J Clin Oncol. 2007;25(19):2755\u201363. https:\/\/doi.org\/10.1200\/JCO.2006.10.4117.","journal-title":"J Clin Oncol"},{"key":"3886_CR20","unstructured":"Comprehensive Cancer Network (NCCN). Uterine Neoplasms (Version 1.2025)."},{"issue":"4","key":"3886_CR21","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/1097-0142(19830815)52:4<626::aid-cncr2820520409>3.0.co;2-e","volume":"52","author":"GA Omura","year":"1983","unstructured":"Omura GA, Major FJ, Blessing JA, Sedlacek TV, Thigpen JT, Creasman WT, et al. A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas. Cancer. 1983;52(4):626\u201332. https:\/\/doi.org\/10.1002\/1097-0142(19830815)52:4%3c626::aid-cncr2820520409%3e3.0.co;2-e.","journal-title":"Cancer"},{"issue":"2","key":"3886_CR22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1006\/gyno.1996.0220","volume":"62","author":"G Sutton","year":"1996","unstructured":"Sutton G, Blessing JA, Malfetano JH. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol. 1996;62(2):226\u20139. https:\/\/doi.org\/10.1006\/gyno.1996.0220.","journal-title":"Gynecol Oncol"},{"key":"3886_CR23","doi-asserted-by":"publisher","unstructured":"Judson I, Verweij J, Gelderblom H, Hartmann JT, Sch\u00f6ffski P, Blay JY, Kerst JM, Sufliarsky J, Whelan J, Hohenberger P, Krarup-Hansen A, Alcindor T, Marreaud S, Liti\u00e8re S, Hermans C, Fisher C, Hogendoorn PC, dei Tos AP, van der Graaf WT; European Organisation and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncol. 2014;15(4):415\u201323. https:\/\/doi.org\/10.1016\/S1470-2045(14)70063-4.","DOI":"10.1016\/S1470-2045(14)70063-4"},{"issue":"4","key":"3886_CR24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S1470-2045(15)70070-7","volume":"16","author":"P Pautier","year":"2015","unstructured":"Pautier P, Floquet A, Chevreau C, Penel N, Guillemet C, Delcambre C, et al. Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial. Lancet Oncol. 2015;16(4):457\u201364. https:\/\/doi.org\/10.1016\/S1470-2045(15)70070-7.","journal-title":"Lancet Oncol"},{"issue":"10","key":"3886_CR25","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/S1470-2045(17)30622-8","volume":"18","author":"B Seddon","year":"2017","unstructured":"Seddon B, Strauss SJ, Whelan J, Leahy M, Woll PJ, Cowie F, et al. Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial. Lancet Oncol. 2017;18(10):1397\u2013410. https:\/\/doi.org\/10.1016\/S1470-2045(17)30622-8.","journal-title":"Lancet Oncol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03886-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03886-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03886-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T07:02:52Z","timestamp":1763449372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03886-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3886"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03886-1","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from the Institutional Review Board of Ege University Hospital (Izmir, Turkey) on March 6, 2025 (Approval No: 25-3\u00a0T\/50), in accordance with the Declaration of Helsinki and local ethical regulations. Patient consent was waived due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final version of the manuscript and consent to its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2114"}}